National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
IN THIS ISSUE
Proteomics: Research for the 21st Century

Proteomics in Clinical Trials

Animation/VideoAnimation/Video

Audio ClipsAudio Clips

Photos/StillsPhotos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
 
    View All Issues  

MEDIA RESOURCES
Noticias En Español

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page...
Benchmarks
------
VOLUME 2, ISSUE 2
------
Animation/Video

TRANSCRIPT: Part 1: Clinical Proteomic Pathways


The code of a cell's gene is read by something called a ribosome, which then helps produce proteins from the genetic code.

Some proteins contain receptors that protrude through the cell wall to receive information from incoming molecules. When an outside substance or molecule docks with the protein receptor, the first step in a protein's signaling pathway is initiated. This signaling starts a cascade of signals from one protein to the next as each protein folds and changes its shape in response to the signaling.

The message ends up reaching the control center of the cell, its nucleus.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov